Connect with us

Health

Thai medicines generated Bt80mln ($2.66mln) revenue

Thai medicines have made headway into the ASEAN market, generating around Bt80 million in revenue last year as pharmaceuticals registered in the ASEAN region.

Avatar

Published

on

Thai medicines have made headway into the ASEAN market, generating around Bt80 million in revenue last year as pharmaceuticals registered in the ASEAN region.

Government Pharmaceutical Organisation GPO Director Dr Vithit Attavechakul said Thailand has advanced in manufacturing medicines for chronic diseases which are widely exported to several ASEAN countries, mainly Cambodia, Myanmar, Laos, and Vietnam.Anti-viral drugs for AIDS, anti-diabetic, and anti high-blood pressure drugs are most popular among all medicines.

Thai medicines plant

Thai medicines generated around Bt80 million in revenue last year as pharmaceuticals registered in the ASEAN region.

 

Dr Vithit said the popularity gained was because consumers were confident of the quality of Thai drugs which are standardised under the GPO and sold both in hospitals and drugstores.

He noted that GPO next week will negotiate with Indonesias equivalent of the Food and Drug Administration to register Thai medicines there. There could also be a joint investment for medications manufacturing in Indonesia.

via Thai medicines penetrate ASEAN market, generating Bt80 mln revenue | MCOT.net.

GPO’s policy is to be the leading domestic drug manufacturer and exporter to the AEC by 2015 in order to accommodate treatment via the country’s public health system and to accommodate free trade for the medicine business and the AEC. Research and development for drug formulas requires bioequivalence and in vitro studies required to represent the efficacy of the drug and to submit for the drug registration to FDA.

The Research and Development Institute, GPO, therefore, established a Bioequivalence Study Center in 2007 by renovating the laboratory and procuring the necessary tools and equipment with a budget of 15 Million Baht in order to apply for Laboratory Quality Standards certification.

At present, GPO is collaborating with a leading Indian Contract Research Organization (CRO) which has provided both clinical research and bioequivalence study services in India, Canada, Poland, the United Kingdom and the United States of America, worked as a consultant for GPO and provided the transfer of the necessary technology to elevate GPO’s Bioequivalence Study Center to a level where it could receive international standard accreditation from organizations such as WHO and EMEA. This is to accommodate the GPO’s new production plant in Rangsit which requires such accreditation.

Comments

Health

Covid-19: the Latest on Southeast Asia

As 2021 dawns, the coronavirus pandemic continues to develop in Southeast Asia. Many countries are preparing to receive their first vaccine shipments, and a few have already started distributing them.

Avatar

Published

on

Coronavirus Asia

As 2021 dawns, the coronavirus pandemic continues to develop in Southeast Asia. Many countries are preparing to receive their first vaccine shipments, and a few have already started distributing them.

(more…)
Continue Reading

Health

Thailand strengthens COVID-19 control measures

Apart from the capital city, many provinces have also enforced tougher measures to contain COVID-19, with inter-provincial travels now being restricted in some areas.

Avatar

Published

on

According to the Tourism Authority of Thailand (TAT) latest update regarding the Royal Thai Government’s announcement on the strengthened COVID-19 control measures to contain local transmission, 28 provinces are now declared as “highly controlled areas”.

(more…)
Continue Reading

Companies

Thai Firm to produce 200 million doses of Covid-19 vaccine

Thai Firm Siam Bioscience Joins with AstraZeneca to Make COVID-19 Vaccine for Southeast Asia and says it will produce 200 million doses of its anti-coronavirus vaccine in Thailand next year.

Olivier Languepin

Published

on

Thailand aims to vaccinate up to half of its population against Covid-19 next year according to the director of its National Vaccine Institute, Dr. Nakorn Premsri.

(more…)
Continue Reading

Latest

Most Viewed

Subscribe via Email

Enter your email address to subscribe and receive notifications of new posts by email.

Join 13,609 other subscribers

Trending